Author reply addresses methodological considerations regarding immunoadsorption versus sham treatment in post-COVID syndrome, highlighting rigorous trial design standards.
Drs. Mansori and Soltani-Kermanshahi raise some important points regarding the methodological validity of the IAMPOCO study.1 We appreciate their interest and scrutiny and would like to take the opportunity to address their comments.
No takes yet. Share an insight, caveat, or question.
Kraus et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: